Baader Bank Aktiengesellschaft’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-83,864	Closed	-$1.91K	–	534
2025 Q1	$1.91K	Buy	83,864 +61,772	+280%	+$10.4K	﹤0.01%	419
2024 Q4	$4.54K	Buy	+22,092	New	+$26.5K	﹤0.01%	372

Baader Bank Aktiengesellschaft's SYRS Position: Q2 2025 in Review

Baader Bank Aktiengesellschaft sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2025, closing a stake of 83,864 shares — an estimated $1.91K sold.

Baader Bank Aktiengesellschaft first reported a position in SYRS in Q4 2024 and held it in 2 quarters. The position peaked at $4.54K in Q4 2024. 0 funds tracked by Wall St. Rank hold SYRS as of Q2 2025.

Baader Bank Aktiengesellschaft reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 83,864 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2025, an estimated $1.91K.
Baader Bank Aktiengesellschaft first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2024 and held it in 2 quarters.
Baader Bank Aktiengesellschaft's Syros Pharmaceuticals, Inc. Common Stock position peaked at $4.54K in Q4 2024.
0 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2025, filed 10 Jul 2025.